CAT No: CP27944
CAS No:102971-73-3
Synonyms/Alias:102971-73-3;Fmoc-Cys(tert-butoxycarnylpropyl)-OH;(R)-Fmoc-2-amino-3-(3-tert-butoxycarbonyl-propylsulfanyl)-propionic acid;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[4-[(2-methylpropan-2-yl)oxy]-4-oxobutyl]sulfanylpropanoic acid;N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(4-(tert-butoxy)-4-oxobutyl)-L-cysteine;MFCD11226818;SCHEMBL5056936;AKOS025289421;DS-9772;HY-W048681;DA-53289;FF157403;Fmoc-Cys(3-(t-butoxycarbonyl)-propyl)-OH;CS-0100981;C71124;Fmoc-Cys(tert-butoxycarnylpropyl)-OH (Fmoc-L-Cys(PrCO-OtBu)-OH);(R)-2-(Fmoc-amino)-3-[[4-(tert-butoxy)-4-oxobutyl]thio]propionic Acid;(R)-Fmoc-2-amino-3-(3-tert-butoxycarbonyl-propylsulfanyl)propionic acid;Fmoc-L-Cys(tert-butoxycarbonylpropyl)-OH;
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.